Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer) - Image 1

£56.86

Morgan & Claypool Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer)

Name: Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer)
Brand: Morgan & Claypool
Price: 56.86 GBP
Availability: InStock

Oncology

This is the usual price. Wait for it to drop, or tell us your number.

£57 today · usual range £0–£0 · best ever £42

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 638 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £55-58 (255 days, 40.0%)

Price range: £42 - £58

Price levels: 5 price ranges over 638 days

Description

The vascular endothelial growth factor (VEGF) family members that include VEGF-A, -B, -C, -D, and placental growth factor (PlGF), display distinct binding affinities for their receptors VEGFR-1, -2, and/or -3. In addition to their requirements in the initiation, development, and maintenance of blood and lymphatic vasculature, VEGFs and VEGFRs are upregulated during neoplasia and are involved in the remodeling of tumoral blood and lymphatic vasculature. By activating VEGFR-1 and VEGFR-2, both expressed on blood endothelial cells, VEGF-A promotes the formation of new tumoral blood vessels and thereby accelerates tumor growth. In contrast, upregulation of VEGF-C, a ligand for lymphatic endothelial VEGFR-3 as well as for VEGFR-2, induces the formation of tumor-associated lymphatic vessels and thus promotes the passive metastatic dissemination of tumor cells to regional lymph nodes. Of the VEGF family members, only VEGF-C and -D were found to be proteolytically processed by Furin-like enzymes. This processing controls the selective activation of VEGFR-2 and -3 signaling during tumor angiogenesis and lymphangiogenesis. Here, we provide an overview of angiogenesis processes and discuss the importance of VEGF-C and VEGF-D precursors processing by the proprotein convertases during the activation of VEGFR-2 and VEGFR-3 receptors and the mediation of their functions during angiogenesis, lymphangiogenesis, and tumorigenesis. About the Author University of Bordeaux, LAMC, UMR 1029, F-3400 and INSERM U1029, FranceResearch Director, INSERM, and, University of Bordeaux

Product Specifications

Brand: Morgan & Claypool
Format: Paperback
ASIN: 1615046100
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 30 November 2013
Listed Since: 08 December 2013

Barcode

No barcode data available

Morgan & Claypool Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Angiogenesis in Health, Disease and Malignancy

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Angiogenesis Inhibition: 180 (Recent Results in Cancer Research, 180)

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)

Angiogenesis Protocols: 467 (Methods in Molecular Biology, 467)

Angiogenesis Protocols: 1430 (Methods in Molecular Biology, 1430)

Angiogenesis: Biology and Pathology (Cold Spring Harbor Perspectives in Medicine)

Angiogenesis: Molecular Biology, Clinical Aspects: 263 (NATO Science Series A:, 263)

Molecular, Cellular, and Clinical Aspects of Angiogenesis: 285 (NATO Science Series A:, 285)

Arteriogenesis and Therapeutic Angiogenesis

Angiogenesis: An Integrative Approach from Science to Medicine

Vascular Development: 283 (Novartis Foundation Symposia)

Antiangiogenic Cancer Therapy

Perspectives in Cancer Prevention-Translational Cancer Research

Springer Angiogenesis: Biochemical Basis and Therapeutics

Therapeutic Angiogenesis for Vascular Diseases: Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease

Anti-Angiogenesis Drug Discovery and Development: Volume 2

Angiogenesis: Methods and Protocols: 2441 (Methods in Molecular Biology, 2441)

A History of Angiogenesis: Discoveries, Research and the Therapeutic Potential (BASIC AND CLINICAL ANGIOGENESIS)

Modeling Tumor Vasculature: Molecular, Cellular, and Tissue Level Aspects and Implications

Mechanical and Chemical Signaling in Angiogenesis: 12 (Studies in Mechanobiology, Tissue Engineering and Biomaterials, 12)

Angiogenesis in Health, Disease and Malignancy

Anti-Angiogenic Functional and Medicinal Foods: 6 (Nutraceutical Science and Technology)